Lipid nanoparticles (LNPs) are advanced drug delivery systems designed to encapsulate and transport therapeutic molecules, including RNA-based treatments. They enhance drug stability, bioavailability, and targeted delivery, making them valuable in nanomedicine. Researchers continue to refine LNP formulations to improve treatment efficacy and reduce side effects in various medical applications.